Pharmacogenetics of hypersensitivity drug reactions.

Therapie

Pharmacology department, faculty of medicine Paris-Sud, UMR 1184, CEA, DSV/iMETI, division of immuno-virology, IDMIT, Inserm center for immunology of viral infections and autoimmune diseases, hôpital Bicêtre, university Paris Sud, Assistance publique-Hôpitaux de Paris, 94275 Le Kremlin-Bicêtre, France.

Published: April 2017

Adverse drug reactions are a significant cause of morbidity and mortality and represent a major burden on the healthcare system. Some of those reactions are immunologically mediated (hypersensitivity reactions) and can be clinically subdivided into two categories: immediate reactions (IgE-related) and delayed reactions (T-cell-mediated). Delayed hypersensitivity reactions include both systemic syndromes and organ-specific toxicities and can be triggered by a wide range of chemically diverse drugs. Recent studies have demonstrated a strong genetic association between human leukocyte antigen alleles and susceptibility to delayed drug hypersensitivity. Most notable examples include human leukocyte antigen (HLA)-B*57:01 allele and abacavir hypersensitivity syndrome or HLA-B*15:02 and HLA-B*58:01 alleles related to severe cutaneous reactions induced by carbamazepine and allopurinol, respectively. This review aims to explore our current understanding in the field of pharmacogenomics of HLA-associated drug hypersensitivities and its translation into clinical practice for predicting adverse drug reactions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.therap.2016.12.009DOI Listing

Publication Analysis

Top Keywords

drug reactions
12
reactions
9
adverse drug
8
hypersensitivity reactions
8
human leukocyte
8
leukocyte antigen
8
drug
5
pharmacogenetics hypersensitivity
4
hypersensitivity drug
4
reactions adverse
4

Similar Publications

Barriers to and facilitators of healthcare professionals in ADR reporting in a tertiary care hospital in India.

BMC Health Serv Res

January 2025

Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur , Tamil Nadu, 603203, India.

Introduction: Several adverse drug reactions (ADRs) go unreported within a healthcare setting despite the risks they cause. We therefore decided to conduct this study in order to recognize the obstacles that hinder the healthcare professionals (HCPs) in a tertiary care hospital in Kattankulathur, Tamil Nadu from reporting ADRs and what strategies ought to be implemented.

Methods: We carried out a cross-sectional study among the HCPs such as doctors, pharmacists and nurses within our institution.

View Article and Find Full Text PDF

Hypersensitivity Reactions to Anticonvulsants.

Curr Allergy Asthma Rep

January 2025

Rochester Regional Health, Rochester, NY, USA.

Background: Antiepileptics are the mainstay of treatment for seizure management. Immediate and delayed hypersensitivity reactions associated with antiepileptics are common. It is important to differentiate between these reactions as management and prognosis varies.

View Article and Find Full Text PDF

Ginsenoside Rd (Rd) is a bioactive compound predominantly found in Panax ginseng C.A. Meyer and Panax notoginseng (Burkill) F.

View Article and Find Full Text PDF

Skeletal Editing through Cycloaddition and Subsequent Cycloreversion Reactions.

Acc Chem Res

January 2025

Organisch-Chemisches Institut, Universität Münster, Corrensstrasse 40, 48149 Münster, Germany.

ConspectusSkeletal editing, which involves adding, deleting, or substituting single or multiple atoms within ring systems, has emerged as a transformative approach in modern synthetic chemistry. This innovative strategy addresses the ever-present demand for developing new drugs and advanced materials by enabling precise modifications of molecular frameworks without disrupting essential functional complexities. Ideally performed at late stages of synthesis, skeletal editing minimizes the need for the cost- and labor-intensive processes often associated with synthesis, thus accelerating the discovery and optimization of complex molecular architectures.

View Article and Find Full Text PDF

Tau hyper-phosphorylation has been recognized as an essential contributor to neurodegeneration in Alzheimer's disease (AD) and related tauopathies. In the last decade, tau hyper-phosphorylation has gained considerable concern in AD therapeutic development. Tauopathies are manifested with a broad spectrum of symptoms, from dementia to cognitive decline and motor impairments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!